Polymorphisms of the angiotensin converting enzyme and angiotensin II type 1 receptor genes and renal scarring in non-uropathic children with recurrent urinary tract infection

Nephrology

Volumn 10, Issue 4, 2005, Pages 377-381

  Ece, Aydin ^a   Tekes, Selahattin ^a   Gürkan, Fuat ^a   Bilici, Meki ^a   Budak, Turgay ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

Angiotensin converting enzyme gene; Angiotensin II type 1 receptor gene; Polymorphism; Renal scarring; Urinary tract infection

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; SUCCIMER;

ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC ASSOCIATION; HUMAN; KIDNEY PARENCHYMA; KIDNEY SCAR; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; URINARY TRACT DISEASE; URINARY TRACT INFECTION;

CHILD, PRESCHOOL; CICATRIX; FEMALE; HUMANS; INFANT; KIDNEY DISEASES; MALE; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 1; RECURRENCE; URINARY TRACT INFECTIONS; VESICO-URETERAL REFLUX;

EID: 28444452173     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2005.00430.x     Document Type: Article

References (27)

1. Stokland E, Hellstrom M, Jacobsson B et al. Renal damage one year after first urinary tract infection: Role of dimercaptosuccinic acid scintigraphy. J. Pediatr. 1996; 129: 815-20.
2. Rushton HG. The evaluation of acute pyelonephritis and renal scarring with 99mTc-dimercaptosuccinic acid renal scintigraphy: Evolving concepts and future directions. Pediatr. Nephrol. 1997; 11: 108-20.
3. Rushton HG. Vesicoureteral reflux and scarring. In: Barratt TM, Avner ED, Harmon WE (eds). Pediatric Nephology. Baltimore: Lippincott Williams-Wilkins Co., 1999: 851.
4. Schmidt S, Ritz E. Genetics of the renin-angiotensin system and renal disease: A progress report. Curr. Opin. Nephrol. Hypertens. 1997; 6: 146-51.
5. Özen S, Alikasifoglu M, Saatci U et al. Implications of certain genetic polymorphisms in scarring in vesicoureteric reflux: Importance of ACE polymorphism. Am. J. Kidney Dis. 1999; 34: 140-45.
6. Cho SJ, Lee SJ. ACE gene polymorphism and renal scar in children with acute pyelonephritis. Pediatr. Nephrol. 2002; 17: 491-5.
7. Navis G, van der Kleij FGH, de Zeeuw D, de Jong PE. Angiotensin- converting enzyme gene I/D polymorphism and renal disease. J. Mol. Med. 1999; 77: 781-91.
8. International Society of Nephrology. Polymorphism of the renin angiotensin genes in progressive renal disease. Kidney Int. 1996; 50: 732-44.
9. Bantis C, Ivens K, Kreusser W et al. Influence of genetic polymorphisms of the renin-angiotensin system on IgA nephropathy. Am. J. Nephrol. 2004; 24: 258-67.
10. Schmidt S, Schone N, Ritz E, Diabetic Nephropathy Study Group. Association of ACE gene polymorphism and diabetic nephropathy? Kidney Int. 1995; 47: 1176-81.
11. Oktem F, Sirin A, Bilge I, Emre S, Agachan B, Ispir T. ACE I/D gene polymorphism in primary FSGS and steroid-sensitive nephrotic syndrome. Pediatr. Nephrol. 2004; 19: 384-9.
12. Schiavello T, Burke V, Bogdanova N et al. Angiotensin-converting enzyme activity and the ACE Alu polymorphism in autosomal dominant polycystic kidney disease. Nephrol. Dial. Transplant. 2001; 16: 2323-7.
13. Kostic M, Stankovic A, Zivkovic M et al. ACE and AT1 receptor gene polymorphisms and renal scarring in urinary bladder dysfunction. Pediatr. Nephrol. 2004; 19: 853-7.
14. Jeffers BW, Estacho R, Raynolds MV, Schrier RW. ACE gene polymorphism in NIDDM and its relationship with diabetic nephropathy. Kidney Int. 1997; 52: 473-7.
15. Woo KT, Lau YK, Choong LHL et al. IgA nephropathy: Effects of clinical indices, ACEI/ATRA therapy and ACE gene polymorphism on disease progression. Nephrology 2002; 7: S166-S172.
16. Bernstein KE, Berk BC. The biology of angiotensin II receptors. Am. J. Kidney Dis. 1993; 22: 745-54.
17. Liu KP, Lin CY, Chen HJ, Wei CF, Lee-Chen GJ. Renin-angiotensin polymorphisms in Taiwanese primary vesicoureteral reflux. Pediatr. Nephrol. 2004; 19: 594-601.
18. Haszon I, Friedman AL, Papp F et al. ACE gene polymorphism and renal scarring in primary vesicoureteric reflux. Pediatr. Nephrol. 2002; 17: 1027-31.
19. Miller SA, Dykes DD, Polesky HS. Simple salting out procedure for extraction DNA from human nucleoted cells. Nucleic Acid Res. 1988; 16: 1215-19.
20. Cotton SA, Gbadegesin RA, Williams S, Brenchley PEC, Webb NJA. Role of TGF-β1 in renal parenchymal scarring following childhood urinary tract infection. Kidney Int. 2002; 61: 61-7.
21. Broyer M, Chantler C, Donckerwolcke R, et al. The paediatric registry of the European Dialysis and Transplant Association: 20 years' experience. Pediatr. Nephrol. 1993; 7: 758-68.
22. Erdogan H, Mir S, Serdaroglu E, Berdeli A, Aksu N. Is ACE gene polymorphism a risk factor for renal scarring with low-grade reflux? Pediatr. Nephrol. 2004; 19: 734-7.
23. Pardo R, Malaga S, Coto E et al. Renin-angiotensin system polymorphisms and renal scarring. Pediatr. Nephrol. 2003; 18: 110-14.
24. Park H, Koo J, Kim J, Ha I, Cheong H, Choi Y. Association of angiotensin I converting enzyme gene polymorphism with reflux nephropathy in children. Nephron 2000; 86: 52-5.
25. Yoneda A, Cascio S, Oue T, Chertin B, Puri P. Risk factors for the development of renal parenchymal damage in familial vesicoureteral reflux. J. Urol. 2002; 168: 1704-7.
26. Dudley J, Johnston A, Gardner A, McGraw M. The deletion polymorphism of the ACE gene is not an independent risk factor for renal scarring in children with vesico-ureteric reflux. Nephrol. Dial. Transplant. 2002; 17: 652-4.
27. Rigat B, Hubert C, Alhenc-Gelas F, Cambein F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensinogen and angiotensin converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 1990; 86: 1343-6.